How to Store SLU-PP-332: Stability and Handling, Per the Research

SLU-PP-332 is a synthetic small-molecule agonist of estrogen-related receptor alpha (ERRα), a nuclear receptor studied for its role in mitochondrial biogenesis and oxidative metabolism. It is sold and labelled in the United States as a research-use-only chemical, is not an approved drug, and is not a peptide. That last point matters for storage: most storage advice circulating about "research compounds" is written for lyophilized peptides, and the physical chemistry of a small heterocyclic molecule is not the same as that of a freeze-dried polypeptide. This page separates what the published literature actually supports from what is general laboratory handling principle, and says which is which in every section.

This page is for educational purposes only and is not medical advice; consult a licensed physician before making any health decision. It describes what stability science and product documentation report, not what any individual should do. For the broader framework that applies across compound classes, see how to store peptides; for background on the molecule itself, see the SLU-PP-332 overview.

The Honest Starting Point: No Published Stability Study

Across the verified literature reviewed for this page, there is no peer-reviewed stability, forced-degradation, or shelf-life study of SLU-PP-332 itself. There is no published report describing how long the compound survives at 4 °C, how many freeze-thaw cycles a dimethyl sulfoxide (DMSO) stock tolerates, or what degradation products form under heat or light. Anyone who states a specific SLU-PP-332 half-life in solution is either quoting a supplier's certificate of analysis, which is manufacturer data, not peer-reviewed data, or extrapolating from chemically unrelated compounds.

What the published literature on ERRα does establish is biological context: the receptor is an active target in metabolic and oncologic research. Researchers reported that ERRα was protective against sepsis-induced acute lung injury in rats (PMID 37340376), and a 2024 study reported that RBBP6-mediated ERRα degradation contributed to mitochondrial injury in renal tubular cells in diabetic kidney disease (PMID 39441040). Those are pharmacology findings about the target, not handling data about the agonist, and this page does not treat them as such.

Why "ERRα Degradation" in Papers Is Not Vial Degradation

A recurring point of confusion is the word degradation. In the ERRα literature, degradation refers to regulated destruction of the receptor protein inside living cells, ubiquitin tagging, proteasomal turnover, and the enzymes that reverse it. A 2025 study reported that ailanthone induced triple-negative breast cancer cell death in a process involving inhibition of OTUB1-mediated ERRα deubiquitylation (PMID 39864589), and a separate 2024 study reported that shikonin blocked cancer-associated-fibroblast-induced metastasis by suppressing mitochondrial biogenesis through phosphorylation-dependent degradation of PGC-1α (PMID 38937832). Reviews of targeted protein degradation describe the same intracellular machinery, including N-terminal-dependent degradation routes in cancer cells (PMID 32814541) and bivalent ligand strategies built to exploit it (PMID 30788082).

None of that describes what happens to a milligram of powder in a sealed amber vial. Chemical degradation in storage is hydrolysis, oxidation, photolysis and thermal breakdown, physical processes governed by water, oxygen, light and temperature. Searching the literature for "ERRα degradation" returns cell-biology papers, not stability data, and conflating the two is the single most common error in online storage write-ups about this compound.

Dry Solid vs Solution: The Core Distinction

Across small-molecule and lyophilized-material handling generally, this is general principle, not SLU-PP-332-specific evidence, the dominant variable is whether water is present. A dry solid has very little mobile water, so hydrolytic reactions are slow and the material is comparatively robust. Once a compound is dissolved, hydrolysis, oxidation and microbial growth all become possible, and the practical shelf life typically drops by orders of magnitude.

The dry solid

Research-use certificates of analysis for small molecules of this class commonly specify storage of the dry solid at or below −20 °C, protected from light and moisture, with the vial allowed to equilibrate to room temperature before opening so that atmospheric water does not condense onto cold powder. That is manufacturer guidance and general chemistry convention rather than a published finding, and specific figures vary between suppliers. Hygroscopic solids that absorb ambient humidity can clump or discolour, and a desiccant-protected container is the standard laboratory countermeasure.

Solutions

SLU-PP-332 has limited aqueous solubility and is handled in laboratory settings as a stock in organic solvent, most often DMSO, diluted into vehicle at the point of use. DMSO is strongly hygroscopic, it draws water out of the air every time a vial is opened, and it freezes near 18.5 °C, so stocks held in a standard freezer are solid and must be thawed before use. This is textbook solvent behaviour, not a compound-specific stability result.

Does SLU-PP-332 Need to Be Refrigerated?

There is no published refrigeration study for this compound. What can be said accurately is that cold storage slows essentially all degradation chemistry, and that the laboratory convention for research-use small molecules is colder for the dry solid (typically freezer) than for short-term working solutions (typically refrigerator or freezer depending on solvent). A refrigerator at 2-8 °C is warmer than the −20 °C that most certificates of analysis specify for dry material, so refrigeration is generally treated as a step down from, not equivalent to, freezer storage of powder.

Two practical caveats appear repeatedly in general handling literature. First, domestic frost-free freezers cycle their temperature to prevent ice build-up, which means the contents experience repeated warming; laboratory-grade or manual-defrost units do not. Second, a refrigerator door is the warmest and most temperature-variable position in the appliance.

Shelf Life and Expiry Dating

Expiry dates on research-use chemicals are not the same as pharmaceutical expiry dates. An approved drug product carries an expiry derived from ICH-style stability testing of that exact formulation in that exact container. A research-use compound typically carries a "retest" or "use by" date set by the supplier, often on the basis of analogous chemistry rather than dedicated long-term study of the batch. Because no peer-reviewed stability dataset for SLU-PP-332 exists in the verified literature, any stated shelf life for it traces back to supplier documentation.

Purity figures on a certificate of analysis describe the material at the time of release, usually by HPLC. They describe a snapshot, not a trajectory, and they say nothing about how the compound behaved after shipping, after storage at an unknown temperature, or after a solution was prepared.

Room Temperature and Transport

Suppliers of research-use small molecules routinely ship dry solids at ambient temperature on the reasoning that short excursions of days contribute little to cumulative degradation relative to long-term storage. That logic applies to the dry form; solutions are a different matter, because hydrolysis and microbial growth proceed continuously at room temperature. Light exposure is an independent variable from heat, photolabile compounds degrade in clear glass at refrigerator temperature, which is why amber vials and opaque secondary containers are the default in laboratory practice.

For transport, the generic variables described in handling literature are cumulative time above the labelled storage temperature, humidity exposure once a seal is broken, and physical damage to the closure. Air-cargo holds and vehicle interiors sit at the extremes of the ambient range in both directions.

Freezing and Freeze-Thaw

Freezing is the standard long-term condition for dry research-use solids and for organic stock solutions. The recognised trade-off is the freeze-thaw cycle: each cycle concentrates solutes transiently at the ice boundary, drives local pH shifts in buffered systems, and, in hygroscopic solvents, allows condensation of atmospheric water during thawing. The general laboratory answer to this is single-use aliquoting, dividing a stock into small portions so that each is thawed once, rather than repeatedly opening a single master vial. No published freeze-thaw study specific to SLU-PP-332 exists.

Signs of Degradation Described in Handling Literature

Visual and physical changes are crude indicators, and the absence of a visible change does not establish chemical integrity. The signals described generically in chemical handling practice include:

• Colour change in a solid or solution, often associated with oxidation products.
• Clumping, caking or liquefaction of a dry solid, consistent with moisture uptake.
• Precipitate, cloudiness or particulates in a previously clear solution.
• Failure to redissolve at a concentration that previously dissolved cleanly.
• Loss of vacuum or a compromised stopper, indicating the seal no longer excludes air and water.

Analytical confirmation, HPLC or mass spectrometry, is the only method that actually quantifies remaining parent compound, and it is what distinguishes a stability claim from an impression.

Handling Hazards and Adverse Events: What Studies Report

The verified literature set reviewed here contains no toxicology, occupational-exposure or adverse-event study of SLU-PP-332, and no human trial of the compound. The ERRα papers that do exist describe receptor biology in disease models rather than compound safety: researchers reported that an ESRRA-ATG5-mediated mitophagy axis enhanced arginine metabolism and alleviated diabetic kidney disease in a 2026 study (PMID 41376268), and a separate study reported that a miR-137/ERRα axis mediated chemoresistance in nasopharyngeal carcinoma cells (PMID 34196940). Because no safety dataset exists for the agonist in humans, research-use-only labelling and standard chemical hygiene, gloves, eye protection, avoidance of powder aerosolisation, and documented disposal, represent the operative framework in laboratory settings rather than any compound-specific published guidance.

What Can and Cannot Be Concluded

1. Compound-specific evidence: none. No published stability, shelf-life or freeze-thaw study of SLU-PP-332 appears in the verified set.
2. Manufacturer data: certificates of analysis and supplier storage statements exist, vary between sources, and are not peer-reviewed.
3. General principle: cold, dark, dry storage of dry solids; aliquoting of solvent stocks; minimisation of freeze-thaw; and awareness that DMSO is hygroscopic. These are standard chemistry, applied by analogy.
4. Target biology: well documented, as the ERRα studies cited above show (PMID 39441040), but entirely separate from vial stability.

Storage questions about a compound with no published stability literature are, in the end, questions about how much weight supplier documentation and chemical analogy can bear. Naming that gap is more useful than filling it with numbers no study produced.

References

• RBBP6-Mediated ERRα Degradation Contributes to Mitochondrial Injury in Renal Tubular Cells in Diabetic Kidney Disease (Advanced Science, 2024)
• ESRRA-ATG5-Mediated mitophagy enhances arginine metabolism to alleviate diabetic kidney disease (Autophagy, 2026)
• Ailanthone induces triple-negative breast cancer cells death involving the inhibition of OTUB1-mediated ERRα deubiquitylation (Journal of Advanced Research, 2025)
• Shikonin blocks CAF-induced TNBC metastasis by suppressing mitochondrial biogenesis through GSK-3β/NEDD4-1 mediated phosphorylation-dependent degradation of PGC-1α (Journal of Experimental & Clinical Cancer Research, 2024)
• N-Terminal-Dependent Protein Degradation and Targeting Cancer Cells (Anti-Cancer Agents in Medicinal Chemistry, 2021)
• Bivalent Ligands for Protein Degradation in Drug Discovery (Computational and Structural Biotechnology Journal, 2019)
• ERRα protects against sepsis-induced acute lung injury in rats (Molecular Medicine, 2023)
• miR-137/ERRα axis mediates chemoresistance of nasopharyngeal carcinoma cells (Journal of Cell Communication and Signaling, 2022)